Drug Discovery · Waltham, MA · Founded 2005 · Privately Held (backing)
Developer of novel therapeutic in-situ forming materials designed to improve the clinical-stage drug delivery system. Arsenal Medical is based in Waltham, MA and was founded in 2005. It was valued at $124 million at its later-stage round in Jun 2025, the last priced event on record. It has raised $46.8 million across 4 recorded rounds; the latest was a $6 million early-stage round in May 2019.
PMV mark · valuation
$124.0M
Oct 2026
Priced at
its later-stage round
Jun 2025
Total raised
$46.8M
Last round
Early Stage VC
May 2019
No prints on record
No secondary trades in Arsenal Medical shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Arsenal Medical with a free account
·Watch Arsenal Medical: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Arsenal Medical stock.
